BCL9 anticorps (AA 1119-1328)
-
- Antigène Voir toutes BCL9 Anticorps
- BCL9 (B-Cell CLL/lymphoma 9 (BCL9))
-
Épitope
- AA 1119-1328
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp BCL9 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (fixed cells) (IF/ICC)
- Purification
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
- Immunogène
- Bcl9 (Ile1119-Gly1328)
- Top Product
- Discover our top product BCL9 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 500 μg/mL
- Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store at 4 °C for frequent use. Aliquot and store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
-
- Antigène
- BCL9 (B-Cell CLL/lymphoma 9 (BCL9))
- Autre désignation
- B-Cell CLL/Lymphoma 9 (BCL9 Produits)
- Synonymes
- anticorps lgs, anticorps xbcl9, anticorps legless, anticorps MGC83888, anticorps BCL9, anticorps 2610202E01Rik, anticorps 8030475K17Rik, anticorps A330041G23Rik, anticorps Gm130, anticorps LGS, anticorps B-cell CLL/lymphoma 9 L homeolog, anticorps B-cell CLL/lymphoma 9, anticorps B cell CLL/lymphoma 9, anticorps bcl9.L, anticorps BCL9, anticorps Bcl9
- Pathways
- Stem Cell Maintenance
-